PrEP method switching: will it yield greater coverage of HIV protection? Applying lessons learned from family planning to guide future research in the context of PrEP …
C McGuire, MA Atieno, T Hoke, P Jeckonia… - Current HIV/AIDS …, 2024 - Springer
Abstract Purpose of Review Despite the growing availability of oral PrEP, coverage remains
suboptimal. Through the introduction of additional PrEP methods, including vaginal rings …
suboptimal. Through the introduction of additional PrEP methods, including vaginal rings …
Financing and delivering pre-exposure prophylaxis (PrEP) to end the HIV epidemic
A Killelea, J Johnson, DT Dangerfield II… - Journal of Law …, 2022 - cambridge.org
The US has the tools to end the HIV epidemic, but progress has stagnated. A major gap in
US efforts to address HIV is the under-utilization of medications that can virtually eliminate …
US efforts to address HIV is the under-utilization of medications that can virtually eliminate …
Data Velocity in HIV-Related Implementation Research: Estimating Time From Funding to Publication
Background: Given available effective biomedical and behavioral prevention and treatment
interventions, HIV-related implementation research (IR) is expanding. The rapid generation …
interventions, HIV-related implementation research (IR) is expanding. The rapid generation …
Causal effects of stochastic PrEP interventions on HIV incidence among men who have sex with men
Antiretroviral preexposure prophylaxis (PrEP) is highly effective in preventing human
immunodeficiency virus (HIV) infection, but uptake has been limited and inequitable …
immunodeficiency virus (HIV) infection, but uptake has been limited and inequitable …
Changes in Glomerular Filtration Rate After Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide Fumarate for Human Immunodeficiency Virus …
AS Rivera, K Pak, MT Mefford… - Open Forum Infectious …, 2024 - academic.oup.com
Background Tenofovir alafenamide fumarate (TAF) was promoted as a safer alternative to
tenofovir disoproxil fumarate (TDF) for human immunodeficiency virus oral preexposure …
tenofovir disoproxil fumarate (TDF) for human immunodeficiency virus oral preexposure …
1551. Changes in Glomerular Filtration Rate after Switching from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide Fumarate for HIV Pre-exposure Prophylaxis
Abstract Background In October 2019, tenofovir alafenamide fumarate (TAF) was approved
for oral pre-exposure prophylaxis (PrEP) for preventing human immunodeficiency virus (HIV) …
for oral pre-exposure prophylaxis (PrEP) for preventing human immunodeficiency virus (HIV) …
Financing and Delivering Pre-Exposure Prophylaxis (PrEP) to End the HIV Epidemic
JM Sharfstein - 2030 - HeinOnline
The US has the tools to end the HIV epidemic, but progress has stagnated. A major gap in
US efforts to address HIV is the under-utilization of medications that can virtually eliminate …
US efforts to address HIV is the under-utilization of medications that can virtually eliminate …